Heineken Holding N.V. reports transactions under its current share buyback programme Heineken Holding N.V. reports transactions under its current share buyback programme Amsterdam, 12 January 2026 - Heineken Holding N.V. (EURONEXT:HEIO; OTCQX: HKHHY), hereby reports transaction details related to the first tranche of up to circa €375 million tranche of its share buyback programme of up to circa €750 million as communicated on 12 February 2025. From 5 January 2026 up to and including 9 January 2026 a total of 219,305 shares were repurchased on exchange at an average price of € 61.47. Up...
We hosted our 29th ODDO BHF Forum in Lyon on 8 and 9 January 2026. In total, 220 companies presented over the two days. In the following note, we provide some initial feedback from the companies on Day 2, in addition to Day 1 feedback (Link to Day 1 feedback). Key positive companies were Corbion, DEME, Elia Group, Knorr Bremse, Sulzer, Séché Environnement, Fraport, Vallourec and TUI. More cautious companies were Arkema, Fastned, INWIT, Manitou, Roche Bobois, Téléperformance, and Colonial SFL. T...
Press Release: Sanofi’s Teizeild approved in the EU for patients with stage 2 type 1 diabetes Sanofi’s Teizeild approved in the EU for patients with stage 2 type 1 diabetes Approval based on the TN-10 phase 2 study that demonstrated a significant delay of onset of stage 3 T1D in stage 2 T1D patientsTeizeild represents a potential significant change in the treatment of autoimmune T1D, preventing the natural disease progression protecting beta-cell function Paris, January 12, 2026. The European Commission has approved Teizeild (teplizumab) to delay the onset of stage 3 type 1 diabetes (T1D)...
Communiqué de presse : Teizeild de Sanofi approuvé dans l'UE pour les patients atteints de diabète de type 1 de stade 2 Teizeild de Sanofi approuvé dans l'UE pour les patients atteints de diabète de type 1 de stade 2 Approbation basée sur l’étude de phase 2 TN-10 qui a démontré un retard significatif dans l’apparition du DT1 de stade 3 chez les patients atteints du DT1 de stade 2Teizeild représente un potentiel changement significatif dans le traitement du DT1 auto-immun en empêchant la progression naturelle de la maladie, en protégeant la fonction des cellules bêta Paris, le 12 janvier 2...
Participation notification by Morgan Stanley Press release Regulated information Brussels, January 6, 2026, 17:45 CET In line with Belgian transparency legislation (Law of May 2, 2007), Morgan Stanley recently sent to Solvay the following transparency notification indicating that they crossed the threshold of 3%. Here is a summary of the notification Voting rights after the transactionEquivalent financial instruments after the transactionTotalPrevious0.13%3.17%3.30%New0.00%-0.00% The notification, dated December 31, 2025...
Notification de participation par Morgan Stanley Communiqué de presse Information réglementée Bruxelles, le 6 janvier 2026 - 17h45 CET Conformément à la législation et réglementation en matière de transparence financière (loi du 2 mai 2007), Morgan Stanley a envoyé récemment à Solvay la notification de transparence suivante indiquant avoir franchi le seuil de 3%. Voici un résumé de la notification: Droits de vote après la transaction Instruments financiers équivalents après la transaction Tota...
Participatiemelding van Morgan Stanley Persbericht Gereglementeerde informatie Brussel, 6 januari 2026 - 17u45 CET In overeenstemming met de Belgische transparantiewetgeving (Wet van 2 mei 2007) heeft Morgan Stanley onlangs de volgende transparantiekennisgeving naar Solvay gestuurd om aan te geven dat ze de drempel van 3% heeft overschreden. Hier is een samenvatting van de beweging: Stemrechten na de transactieAan stemrechten gelijkgestelde financiële instrumenten na de transactieTotaalVorige0,13%3,17%3,30%Nieuw0,00%-0,00%...
Heineken Holding N.V. reports transactions under its current share buyback programme Heineken Holding N.V. reports transactions under its current share buyback programme Amsterdam, 5 January 2026 - Heineken Holding N.V. (EURONEXT:HEIO; OTCQX: HKHHY), hereby reports transaction details related to the first tranche of up to circa €375 million tranche of its share buyback programme of up to circa €750 million as communicated on 12 February 2025. From 29 December 2025 up to and including 2 January 2026 a total of 5,641 shares were repurchased on exchange at an average price of € 62.10. Up ...
Press Release: Sanofi’s Tzield accepted for priority review in the US for young children with stage 2 type 1 diabetes Sanofi’s Tzield accepted for priority review in the US for young children with stage 2 type 1 diabetes If approved, Tzield would be the first disease-modifying therapy to delay the onset of stage 3 T1D in children aged one and older diagnosed with stage 2 T1DTzield slows disease progression by protecting the insulin-secreting beta cells of the pancreasThe priority review is based on interim results from the PETITE-T1D phase 4 study Paris, January 5, 2026. The US Food and D...
Communiqué de presse : Le médicament Tzield de Sanofi a été accepté pour un examen prioritaire aux États-Unis pour les jeunes enfants atteints de diabète de type 1 de stade 2 Le médicament Tzield de Sanofi a été accepté pour un examen prioritaire aux États-Unis pour les jeunes enfants atteints de diabète de type 1 de stade 2 Si elle est approuvée, Tzield serait la première thérapie modifiant l’évolution de la maladie en retardant l’apparition du diabète de type 1 de stade 3 chez les enfants âgés d’un an et plus chez lesquels un diabète de type 1 de stade 2 a été diagnostiqué.Tzield ralenti...
Heineken Holding N.V. reports transactions under its current share buyback programme Heineken Holding N.V. reports transactions under its current share buyback programme Amsterdam, 29 December 2025 - Heineken Holding N.V. (EURONEXT:HEIO; OTCQX: HKHHY), hereby reports transaction details related to the first tranche of up to circa €375 million tranche of its share buyback programme of up to circa €750 million as communicated on 12 February 2025. From 22 December 2025 up to and including 26 December 2025 a total of 103,476 shares were repurchased on exchange at an average price of € 61...
COMPAÑÍAS QUE APARECEN EN EL INFORME: ESPAÑA: ACCIONA ENERGÍA, GRIFOLS. EUROPA: SANOFI. El PIB de EE.UU. anima las bolsas Jornada de menos a más en las bolsas europeas, que tras el buen dato de PIB en EE.UU. dejaron las pérdidas atrás. En el STOXX 600, Farma y R. Básicos fueron los sectores que más subieron frente a Viajes&Ocio y Media que fueron los que peor comportamiento relativo mostraron. Por el lado macro, en España el PIB final del 3T’25 confirmó el 2,8% a/a preliminar. En EE.UU. el PIB...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.